{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:18:33Z","timestamp":1781194713687,"version":"3.54.1"},"reference-count":88,"publisher":"Elsevier","isbn-type":[{"value":"9780323907316","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010798","name":"Sunway University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010798","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.vh.2021.06.008","type":"book-chapter","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T21:20:29Z","timestamp":1629408029000},"page":"17-46","source":"Crossref","is-referenced-by-count":1,"title":["Strategies to identify and develop antiviral peptides"],"prefix":"10.1016","member":"78","reference":[{"issue":"6","key":"10.1016\/bs.vh.2021.06.008_bb0010","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3390\/ijms20061256","article-title":"Advances in antigenic peptide-based vaccine and neutralizing antibodies against viruses causing hand, foot, and mouth disease","volume":"20","author":"Anasir","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/bs.vh.2021.06.008_bb0015","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/JVI.01840-06","article-title":"Antiviral peptides targeting the West Nile virus envelope protein","volume":"81","author":"Bai","year":"2007","journal-title":"Journal of Virology"},{"issue":"4","key":"10.1016\/bs.vh.2021.06.008_bb0020","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/med.21658","article-title":"Machine intelligence in peptide therapeutics: A next-generation tool for rapid disease screening","volume":"40","author":"Basith","year":"2020","journal-title":"Medicinal Research Reviews"},{"issue":"1","key":"10.1016\/bs.vh.2021.06.008_bb0025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1074\/jbc.M114.608315","article-title":"Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation","volume":"290","author":"Bastian","year":"2015","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.vh.2021.06.008_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nchembio.1982","article-title":"Molecular mechanism of respiratory syncytial virus fusion inhibitors","volume":"12","author":"Battles","year":"2016","journal-title":"Nature Chemical Biology"},{"issue":"2","key":"10.1016\/bs.vh.2021.06.008_bb0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0166-3542(02)00069-4","article-title":"Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides","volume":"55","author":"Berkhout","year":"2002","journal-title":"Antiviral Research"},{"issue":"6","key":"10.1016\/bs.vh.2021.06.008_bb0040","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1208\/s12249-018-1085-1","article-title":"Metformin-loaded hyaluronic acid nanostructure for oral delivery","volume":"19","author":"Bhujbal","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/bs.vh.2021.06.008_bb0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/bip.10398","article-title":"Successful identification of novel agents to control infectious diseases from screening mixture-based peptide combinatorial libraries in complex cell-based bioassays","volume":"71","author":"Boggiano","year":"2003","journal-title":"Peptide Science"},{"issue":"2","key":"10.1016\/bs.vh.2021.06.008_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41578-019-0156-6","article-title":"Materials for oral delivery of proteins and peptides","volume":"5","author":"Brown","year":"2019","journal-title":"Nature Reviews Materials"},{"key":"10.1016\/bs.vh.2021.06.008_bb0055","article-title":"An update-prolonging the action of protein and peptide drugs","volume":"61","author":"Cao","year":"2020","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"5","key":"10.1016\/bs.vh.2021.06.008_bb0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1208\/s12249-019-1325-z","article-title":"Nanoparticles: Oral delivery for protein and peptide drugs","volume":"20","author":"Cao","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/bs.vh.2021.06.008_bb0065","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.3390\/molecules16053499","article-title":"Phage display of combinatorial peptide libraries: Application to antiviral research","volume":"16","author":"Castel","year":"2011","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/bs.vh.2021.06.008_bb0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4149\/av_2018_222","article-title":"Induction and antiviral activity of human \u03b2-defensin 3 in intestinal cells with picornavirus infection","volume":"62","author":"Chen","year":"2018","journal-title":"Acta Virologica"},{"issue":"7","key":"10.1016\/bs.vh.2021.06.008_bb0075","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.vaccine.2007.12.013","article-title":"Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonatal mice from a lethal challenge with enterovirus type 71","volume":"26","author":"Chen","year":"2008","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/bs.vh.2021.06.008_bb0080","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/jac\/dku183","article-title":"The MT hook structure increases the potency of HIV-1 fusion inhibitor sifuvirtide and overcomes drug resistance","volume":"69","author":"Chong","year":"2014","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/bs.vh.2021.06.008_bb0085","author":"ClinicalTrials"},{"key":"10.1016\/bs.vh.2021.06.008_bb0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.antiviral.2018.04.018","article-title":"Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with \u03b23 integrin","volume":"155","author":"Cui","year":"2018","journal-title":"Antiviral Research"},{"key":"10.1016\/bs.vh.2021.06.008_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1827341","article-title":"Phage-displayed peptides selected to bind envelope glycoprotein show antiviral activity against dengue virus serotype 2","volume":"2017","author":"de la Guardia","year":"2017","journal-title":"Advances in Virology"},{"issue":"10","key":"10.1016\/bs.vh.2021.06.008_bb0100","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40262-013-0079-0","article-title":"Pharmacokinetics and pharmacokinetic\u2013pharmacodynamic correlations of therapeutic peptides","volume":"52","author":"Diao","year":"2013","journal-title":"Clinical Pharmacokinetics"},{"issue":"31","key":"10.1016\/bs.vh.2021.06.008_bb0105","doi-asserted-by":"crossref","first-page":"12772","DOI":"10.1073\/pnas.0701478104","article-title":"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus","volume":"104","author":"Dwyer","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.vh.2021.06.008_bb0110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/JVI.78.2.568-575.2004","article-title":"Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides","volume":"78","author":"Egelhofer","year":"2004","journal-title":"Journal of Virology"},{"issue":"12","key":"10.1016\/bs.vh.2021.06.008_bb0115","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/jac\/dks304","article-title":"Blocking human enterovirus 71 replication by targeting viral 2A protease","volume":"67","author":"Falah","year":"2012","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"7","key":"10.1016\/bs.vh.2021.06.008_bb0120","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1128\/JVI.73.7.5795-5802.1999","article-title":"Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries","volume":"73","author":"Ferrer","year":"1999","journal-title":"Journal of Virology"},{"issue":"6","key":"10.1016\/bs.vh.2021.06.008_bb0125","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.nano.2015.03.009","article-title":"Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice","volume":"11","author":"Fiandra","year":"2015","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"issue":"4","key":"10.1016\/bs.vh.2021.06.008_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02241-16","article-title":"A short double-stapled peptide inhibits respiratory syncytial virus entry and spreading","volume":"61","author":"Gaillard","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"24","key":"10.1016\/bs.vh.2021.06.008_bb0135","doi-asserted-by":"crossref","first-page":"13134","DOI":"10.1128\/JVI.02433-13","article-title":"Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus","volume":"87","author":"Gao","year":"2013","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.vh.2021.06.008_bb0140","series-title":"Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof","author":"Gripon","year":"2011"},{"issue":"8","key":"10.1016\/bs.vh.2021.06.008_bb0145","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1517\/13543784.9.8.1723","article-title":"Cationic antimicrobial peptides: Towards clinical applications","volume":"9","author":"Hancock","year":"2000","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"42","key":"10.1016\/bs.vh.2021.06.008_bb0150","doi-asserted-by":"crossref","first-page":"16332","DOI":"10.1073\/pnas.0807335105","article-title":"Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains","volume":"105","author":"He","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"10.1016\/bs.vh.2021.06.008_bb0155","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02251-17","article-title":"Fibronectin facilitates enterovirus 71 infection by mediating viral entry","volume":"92","author":"He","year":"2018","journal-title":"Journal of Virology"},{"issue":"17","key":"10.1016\/bs.vh.2021.06.008_bb0160","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1074\/jbc.M800200200","article-title":"Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor","volume":"283","author":"He","year":"2008","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.vh.2021.06.008_bb0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jmv.10266","article-title":"Selection of high affinity ligands to hepatitis B core antigen from a phage-displayed cyclic peptide library","volume":"69","author":"Ho","year":"2003","journal-title":"Journal of Medical Virology"},{"issue":"12","key":"10.1016\/bs.vh.2021.06.008_bb0170","first-page":"1769","article-title":"Selection of peptides binding to HCV e2 and inhibiting viral infectivity","volume":"20","author":"Hong","year":"2010","journal-title":"Journal of Microbiology and Biotechnology"},{"issue":"22","key":"10.1016\/bs.vh.2021.06.008_bb0175","doi-asserted-by":"crossref","first-page":"19799","DOI":"10.1021\/acsami.9b04240","article-title":"Novel gold nanorod-based HR1 peptide inhibitor for Middle East respiratory syndrome coronavirus","volume":"11","author":"Huang","year":"2019","journal-title":"ACS Applied Materials & Interfaces"},{"issue":"1","key":"10.1016\/bs.vh.2021.06.008_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10867-018-9515-6","article-title":"Dynamics and binding interactions of peptide inhibitors of dengue virus entry","volume":"45","author":"Isa","year":"2019","journal-title":"Journal of Biological Physics"},{"issue":"3","key":"10.1016\/bs.vh.2021.06.008_bb0185","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/JVI.02979-14","article-title":"Characterization of a proteolytically stable D-peptide that suppresses herpes simplex virus 1 infection: Implications for the development of entry-based antiviral therapy","volume":"89","author":"Jaishankar","year":"2015","journal-title":"Journal of Virology"},{"issue":"2","key":"10.1016\/bs.vh.2021.06.008_bb0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2003.09.001","article-title":"Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate","volume":"61","author":"Jenssen","year":"2004","journal-title":"Antiviral Research"},{"issue":"6","key":"10.1016\/bs.vh.2021.06.008_bb0195","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000442588","article-title":"Recombinant mouse \u03b2-defensin 3 protects against Coxsackievirus B3-induced myocarditis in mice","volume":"58","author":"Jiang","year":"2015","journal-title":"Intervirology"},{"issue":"24","key":"10.1016\/bs.vh.2021.06.008_bb0200","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1128\/JVI.01678-06","article-title":"Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells","volume":"80","author":"Jones","year":"2006","journal-title":"Journal of Virology"},{"issue":"Suppl. 1","key":"10.1016\/bs.vh.2021.06.008_bb0205","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/ofid\/ofv133.901","article-title":"Analysis of GS-5806 resistance emergence in human healthy adult subjects experimentally infected with respiratory syncytial virus (RSV)","volume":"2","author":"Jordan","year":"2015","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/bs.vh.2021.06.008_bb0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.antiviral.2015.10.006","article-title":"Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16","volume":"124","author":"Kelly","year":"2015","journal-title":"Antiviral Research"},{"issue":"1","key":"10.1016\/bs.vh.2021.06.008_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-020-0615-9","article-title":"Cellular receptors for enterovirus A71","volume":"27","author":"Kobayashi","year":"2020","journal-title":"Journal of Biomedical Science"},{"issue":"11","key":"10.1016\/bs.vh.2021.06.008_bb0220","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/psc.1388","article-title":"Further studies on the antiviral activity of alloferon and its analogues","volume":"17","author":"Kuczer","year":"2011","journal-title":"Journal of Peptide Science"},{"issue":"21","key":"10.1016\/bs.vh.2021.06.008_bb0225","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1002\/anie.201702005","article-title":"Multivalent peptide\u2013nanoparticle conjugates for Influenza virus inhibition","volume":"56","author":"Lauster","year":"2017","journal-title":"Angewandte Chemie International Edition"},{"issue":"11","key":"10.1016\/bs.vh.2021.06.008_bb442","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/ncb1980","article-title":"FLIP-mediated autophagy regulation in cell death control","volume":"11","author":"Lee","year":"2009","journal-title":"Nature Cell Biology"},{"issue":"1","key":"10.1016\/bs.vh.2021.06.008_bb0230","first-page":"S183","article-title":"The therapeutic potential of secreted antiviral entry inhibitor (SAVE) peptides expressed by transduced MSCs to block HIV infection","volume":"22","author":"Lee","year":"2014","journal-title":"Molecular Therapy"},{"issue":"1","key":"10.1016\/bs.vh.2021.06.008_bb0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/17425247.2017.1360863","article-title":"Nanomedicine formulations for the delivery of antiviral drugs: A promising solution for the treatment of viral infections","volume":"15","author":"Lembo","year":"2018","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"8","key":"10.1016\/bs.vh.2021.06.008_bb0240","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/343809","article-title":"Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro","volume":"186","author":"Lin","year":"2002","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1016\/bs.vh.2021.06.008_bb0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: The rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discovery Today: Technologies"},{"key":"10.1016\/bs.vh.2021.06.008_bb0250","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.compbiomed.2019.02.011","article-title":"AntiVPP 1.0: A portable tool for prediction of antiviral peptides","volume":"107","author":"Lissabet","year":"2019","journal-title":"Computers in Biology and Medicine"},{"issue":"2","key":"10.1016\/bs.vh.2021.06.008_bb0255","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","article-title":"Current progress in antiviral strategies","volume":"35","author":"Lou","year":"2014","journal-title":"Trends in Pharmacological Sciences"},{"issue":"1","key":"10.1016\/bs.vh.2021.06.008_bb0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virol.2009.12.017","article-title":"Targeting enteroviral 2A protease by a 16-mer synthetic peptide: Inhibition of 2Apro-induced apoptosis in a stable Tet-on HeLa cell line","volume":"399","author":"Maghsoudi","year":"2010","journal-title":"Virology"},{"issue":"4","key":"10.1016\/bs.vh.2021.06.008_bb441","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004300050093","article-title":"Inhibition of poliovirus type 1 infection by iron-, manganese-and zinc-saturated lactoferrin","volume":"187","author":"Marchetti","year":"1999","journal-title":"Medical Microbiology and Immunology"},{"issue":"5","key":"10.1016\/bs.vh.2021.06.008_bb0270","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bmc.2016.01.039","article-title":"Heptapeptide ligands against receptor-binding sites of influenza hemagglutinin toward anti-influenza therapy","volume":"24","author":"Matsubara","year":"2016","journal-title":"Bioorganic and Medicinal Chemistry"},{"issue":"5","key":"10.1016\/bs.vh.2021.06.008_bb0275","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1365-2672.2003.02071.x","article-title":"The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures","volume":"95","author":"McCann","year":"2003","journal-title":"Journal of Applied Microbiology"},{"key":"10.1016\/bs.vh.2021.06.008_bb0280","series-title":"Structure and physics of viruses","first-page":"599","article-title":"Antiviral agents: Structural basis of action and rational design","author":"Men\u00e9ndez-Arias","year":"2013"},{"issue":"2","key":"10.1016\/bs.vh.2021.06.008_bb0285","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2007.02.042","article-title":"Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide","volume":"129","author":"M\u00fcnch","year":"2007","journal-title":"Cell"},{"key":"10.1016\/bs.vh.2021.06.008_bb0290","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3389\/fimmu.2019.01366","article-title":"Peptide antiviral strategies as an alternative to treat lower respiratory viral infections","volume":"10","author":"Nyanguile","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"7","key":"10.1016\/bs.vh.2021.06.008_bb0295","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.chembiol.2018.04.011","article-title":"De novo macrocyclic peptide inhibitors of hepatitis B virus cellular entry","volume":"25","author":"Passioura","year":"2018","journal-title":"Cell Chemical Biology"},{"key":"10.1016\/bs.vh.2021.06.008_bb0300","series-title":"Nanoparticles","author":"Penades","year":"2008"},{"key":"10.1016\/bs.vh.2021.06.008_bb0305","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.coviro.2016.06.002","article-title":"Antiviral targets of human noroviruses","volume":"18","author":"Prasad","year":"2016","journal-title":"Current Opinion in Virology"},{"issue":"6","key":"10.1016\/bs.vh.2021.06.008_bb0310","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/bip.22703","article-title":"AVP-IC50Pred: Multiple machine learning techniques-based prediction of peptide antiviral activity in terms of half maximal inhibitory concentration (IC50)","volume":"104","author":"Qureshi","year":"2015","journal-title":"Peptide Science"},{"issue":"12","key":"10.1016\/bs.vh.2021.06.008_bb0315","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1039\/C7CC08242H","article-title":"Non-natural amino acid peptide microarrays to discover Ebola virus glycoprotein ligands","volume":"54","author":"Rabinowitz","year":"2018","journal-title":"Chemical Communications"},{"issue":"Suppl. 1","key":"10.1016\/bs.vh.2021.06.008_bb0320","first-page":"OR14","article-title":"OR14-1 pharmacodynamics, safety, tolerability, and efficacy of oral insulin formulation (Oshadi Icp) among young adults with type 1 diabetes: A summary of clinical studies phases I, Ib, and Ii","volume":"3","author":"Rachmiel","year":"2019","journal-title":"Journal of the Endocrine Society"},{"issue":"1","key":"10.1016\/bs.vh.2021.06.008_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00170-x","article-title":"Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor","volume":"8","author":"Roymans","year":"2017","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/bs.vh.2021.06.008_bb0330","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/JVI.02139-12","article-title":"Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture","volume":"87","author":"Sadeghipour","year":"2013","journal-title":"Journal of Virology"},{"issue":"5","key":"10.1016\/bs.vh.2021.06.008_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034589","article-title":"Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1","volume":"7","author":"Tan","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.vh.2021.06.008_bb0340","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/JVI.02226-12","article-title":"Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor","volume":"87","author":"Tan","year":"2013","journal-title":"Journal of Virology"},{"key":"10.1016\/bs.vh.2021.06.008_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104792","article-title":"Coronavirus membrane fusion mechanism offers as a potential target for antiviral development","volume":"178","author":"Tang","year":"2020","journal-title":"Antiviral Research"},{"issue":"W1","key":"10.1016\/bs.vh.2021.06.008_bb0350","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gks450","article-title":"AVPpred: Collection and prediction of highly effective antiviral peptides","volume":"40","author":"Thakur","year":"2012","journal-title":"Nucleic Acids Research"},{"issue":"5","key":"10.1016\/bs.vh.2021.06.008_bb0355","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijantimicag.2005.02.011","article-title":"Inhibitory activity of bovine lactoferrin against echovirus induced programmed cell death in vitro","volume":"25","author":"Tinari","year":"2005","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"28","key":"10.1016\/bs.vh.2021.06.008_bb0360","doi-asserted-by":"crossref","first-page":"25406","DOI":"10.1074\/jbc.M110.201103","article-title":"Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo","volume":"286","author":"Tiwari","year":"2011","journal-title":"Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/bs.vh.2021.06.008_bb0365","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s12275-016-6376-1","article-title":"Inhibitory effects of bee venom and its components against viruses in vitro and in vivo","volume":"54","author":"Uddin","year":"2016","journal-title":"Journal of Microbiology"},{"issue":"12","key":"10.1016\/bs.vh.2021.06.008_bb0370","first-page":"742","article-title":"Progress in nanomedicine: Approved and investigational nanodrugs","volume":"42","author":"Ventola","year":"2017","journal-title":"Pharmacy and Therapeutics"},{"key":"10.1016\/bs.vh.2021.06.008_bb0375","series-title":"Inhibitory peptides of viral infection","author":"Wall","year":"2020"},{"key":"10.1016\/bs.vh.2021.06.008_bb0380","series-title":"Progress in drug research","first-page":"197","article-title":"Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections","author":"Wang","year":"1999"},{"issue":"5","key":"10.1016\/bs.vh.2021.06.008_bb0385","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/ph7050545","article-title":"Human antimicrobial peptides and proteins","volume":"7","author":"Wang","year":"2014","journal-title":"Pharmaceuticals"},{"key":"10.1016\/bs.vh.2021.06.008_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/database\/bay038","article-title":"StraPep: A structure database of bioactive peptides","volume":"2018","author":"Wang","year":"2018","journal-title":"Database"},{"key":"10.1016\/bs.vh.2021.06.008_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104673","article-title":"Antiviral activity of phage display-selected peptides against Japanese encephalitis virus infection in vitro and in vivo","volume":"174","author":"Wei","year":"2020","journal-title":"Antiviral Research"},{"issue":"1","key":"10.1016\/bs.vh.2021.06.008_bb0400","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2005.03.005","article-title":"Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells","volume":"67","author":"Weng","year":"2005","journal-title":"Antiviral Research"},{"issue":"21","key":"10.1016\/bs.vh.2021.06.008_bb0405","doi-asserted-by":"crossref","first-page":"11385","DOI":"10.1128\/JVI.01363-09","article-title":"Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease","volume":"83","author":"Wohlford-Lenane","year":"2009","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/bs.vh.2021.06.008_bb0410","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.virusres.2012.08.016","article-title":"Antiviral protection against enterovirus 71 mediated by autophagy induction following FLICE-inhibitory protein inactivation","volume":"169","author":"Won","year":"2012","journal-title":"Virus Research"},{"issue":"10","key":"10.1016\/bs.vh.2021.06.008_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007517","article-title":"Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication","volume":"4","author":"Wunderlich","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.vh.2021.06.008_bb0420","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Research"},{"issue":"4","key":"10.1016\/bs.vh.2021.06.008_bb0425","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Science Advances"},{"issue":"12","key":"10.1016\/bs.vh.2021.06.008_bb0430","first-page":"763","article-title":"Enhancing the oral bioavailability of peptide drugs by using chemical modification and other approaches","volume":"4","author":"Yin","year":"2014","journal-title":"Medicinal Chemistry"},{"key":"10.1016\/bs.vh.2021.06.008_bb0435","series-title":"The first-in-class peptide binder to the SARS-CoV-2 spike protein","author":"Zhang","year":"2020"},{"key":"10.1016\/bs.vh.2021.06.008_bb0440","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.antiviral.2014.01.011","article-title":"Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III","volume":"104","author":"Zu","year":"2014","journal-title":"Antiviral Research"}],"container-title":["Vitamins and Hormones","Hormones, Regulators and Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672921000522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672921000522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:41:09Z","timestamp":1762231269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672921000522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780323907316"],"references-count":88,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2021.06.008","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}